You just read:

Gala Therapeutics Receives FDA IDE Approval for a US Early Feasibility Study of Its RheOx™ System to Treat Chronic Bronchitis

News provided by

Gala Therapeutics, Inc.

Jul 12, 2018, 11:24 ET